US Bancorp’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Sell
116,456
-15,022
-11% -$239K ﹤0.01% 953
2025
Q4
$2.14M Buy
131,478
+4,325
+3% +$70.6K ﹤0.01% 861
2025
Q3
$1.9M Buy
127,153
+8,738
+7% +$106K ﹤0.01% 895
2025
Q2
$1.38M Sell
118,415
-15,636
-12% -$142K ﹤0.01% 1003
2025
Q1
$996K Buy
134,051
+14,764
+12% +$113K ﹤0.01% 1103
2024
Q4
$715K Sell
119,287
-43,819
-27% -$242K ﹤0.01% 1279
2024
Q3
$835K Buy
163,106
+71,065
+77% +$310K ﹤0.01% 1218
2024
Q2
$333K Sell
92,041
-9,063
-9% -$28.8K ﹤0.01% 1733
2024
Q1
$325K Sell
101,104
-9,873
-9% -$38.2K ﹤0.01% 1762
2023
Q4
$544K Buy
110,977
+105,077
+1,781% +$479K ﹤0.01% 1439
2023
Q3
$32.2K Sell
5,900
-1,042
-15% -$6.89K ﹤0.01% 2651
2023
Q2
$46.6K Sell
6,942
-48
-0.7% -$357 ﹤0.01% 2535
2023
Q1
$61.7K Buy
6,990
+362
+5% +$3.19K ﹤0.01% 2410
2022
Q4
$50.6K Sell
6,628
-3,938
-37% -$30.6K ﹤0.01% 2519
2022
Q3
$75K Sell
10,566
-24,744
-70% -$233K ﹤0.01% 2316
2022
Q2
$286K Sell
35,310
-13,282
-27% -$117K ﹤0.01% 1717
2022
Q1
$674K Buy
48,592
+157
+0.3% +$2.47K ﹤0.01% 1384
2021
Q4
$1.36M Buy
48,435
+9,233
+24% +$283K ﹤0.01% 1077
2021
Q3
$1.33M Buy
39,202
+1,679
+4% +$60.7K ﹤0.01% 1048
2021
Q2
$1.53M Buy
37,523
+9,906
+36% +$385K ﹤0.01% 995
2021
Q1
$1.11M Buy
27,617
+3,009
+12% +$163K ﹤0.01% 1079
2020
Q4
$1.46M Sell
24,608
-264
-1% -$13.6K ﹤0.01% 940
2020
Q3
$1.21M Buy
24,872
+1,992
+9% +$83.7K ﹤0.01% 914
2020
Q2
$1.11M Buy
22,880
+14,412
+170% +$525K ﹤0.01% 919
2020
Q1
$235K Buy
8,468
+8,467
+846,700% +$236K ﹤0.01% 1576
2019
Q4
$0 Buy
+1
New +$29 ﹤0.01% 3640

Other funds holding ADPT